✦ LIBER ✦

A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinoma

✍ Scribed by Ross, Helen J.; Hart, Lowell L.; Swanson, Paul M.; Rarick, Mark U.; Figlin, Robert A.; Jacobs, Andrew D.; McCune, David E.; Rosenberg, Arthur H.; Baron, Ari D.; Grove, Laurie E.; Thorn, Michael D.; Miller, Dennis M.; Drachman, Jonathan G.; Rudin, Charles M.

Book ID: 119319428
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 311 KB
Volume: 54
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2006.05.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter phase II study of the effi

A multicenter phase II study of the efficacy and safety of docetaxel plus cisplatin in Asian chemonaı̈ve patients with metastatic or locally advanced non-small cell lung cancer

✍ James C.M. Ho; E.H. Tan; S.S. Leong; C.H. Wang; Y. Sun; R. Li; M.I.A. Wahid; A. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Docetaxel in combination with carboplati

Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma: a multicentre phase I study

✍ T. Giannakakis; N. Ziras; S. Kakolyris; D. Mavroudis; N. Androulakis; S. Agelaki 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 96 KB

A randomized prospective study of radiat

A randomized prospective study of radiation versus radiation plus acnu in inoperable non-small cell carcinoma of the lung

📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 625 KB

Docetaxel plus cisplatin and bevacizumab

Docetaxel plus cisplatin and bevacizumab for untreated patients with advanced/metastatic non-squamous non-small-cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group

✍ N. Kentepozidis, A. Kotsakis, A. Soultati… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 214 KB

A phase II, randomized, multicenter stud

A phase II, randomized, multicenter study to assess the efficacy, safety, and tolerability of zibotentan (ZD4054) in combination with pemetrexed in patients with advanced non-small cell lung cancer

✍ Christos Chouaid; Faith Nathan; Kristine Pemberton; Thomas Morris 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 244 KB

A randomized phase III study of the doce

A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic Non-Small Cell Lung Cancer

✍ Athanasios G Pallis; Sophia Agelaki; Athina Agelidou; Ioannis Varthalitis; Kosta 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 359 KB